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ABSTRACT

Effect of Intravenous Treatment with the Oxytocin Antagonist Atosiban on Circulating
Progesterone in the Ewe

Todd M. Ramboldt

Effects of oxytocin on the ovine corpus luteum have been controversial for a
number of years. The present study investigated the effects of atosiban, a combined
oxytocin and vasopressin 1A antagonist, administered systemically to ewes on post estrus
day 8 to 10. Atosiban was given in four bolus intravenous injections at 0, 60, 120 and 180
minutes with blood sampling every 15 minutes from -60 through 480 minutes.
Concentrations of serum progesterone ng/ml were measured via radioimmunoassay. A
log10 transformation of progesterone values was conducted to account for the
heterogeneity of variance of the values. During the treatment interval (0 to 240 minutes),
log10 concentrations of progesterone were lower in ewes treated with 20 mg (0.99) than in
the 5 or 10 mg treated groups (1.00; P < 0.05). Control ewes (P < 0.0001) differed from
ewes treated with atosiban (5, 10 or 20 mg). During times greater than 240 minutes
(hours 4 to 24), log10 concentrations of progesterone decreased in control ewes (1.04) and
were lower in the ewes treated with 5, 10 or 20 mg (1.01) of atosiban (P < 0.005). There
was also a significant difference (P < 0.05) when comparing the 20 mg group (1.01) to
the ewes treated with 5 and 10 mg of atosiban (1.02). Over the entire sampling period,
mean log10 progesterone concentrations were lower (P < 0.001) in ewes treated with
atosiban (1.00) compared to the control group (1.05). Among doses of atosiban, log10
concentrations of progesterone were lower (P < 0.0001) in ewes treated with 20 mg
(0.99) atosiban than in ewes treated with 5 mg or 10 mg (1.01) atosiban. The overall
effect of systemic treatment with atosiban in this study was to decrease mean log10
concentrations of progesterone relative to control ewes, which is in agreement with
earlier findings using intraluteal infusion. The most effective dose of atosiban was 20
mg. In conclusion, systemic treatment with atosiban decreased concentrations of
progesterone during the treatment phase of the experiment. Atosiban delivered in 20 mg
maintained the lowest values in contrast to the control ewes and ewes treated with 5 or 10
mg of atosiban throughout the duration of the experiment.
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Figure 2. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There was a significant
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0.0001) also when comparing the 20 mg dose to the 5 and 10 mg doses (P < 0.05).

Figure 3. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There were significant
differences for control versus treatment (0 mg vs 5, 10 and 20 mg) (P < 0.005), and
between the high dose versus the lower dosages (20 mg vs 5 and 10 mg) (P < 0.05).

Figure 4. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There were significant
differences for control versus treatment (0 mg vs 5, 10 and 20 mg) (P < 0.0001).
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Introduction

In most spontaneous ovulators, the period of sexual receptivity in females is
referred to as standing heat or estrus (Heape, 1900). Twenty-four to 30 hours after estrus
a surge of luteinizing hormone (LH) (Bindon et al., 1979; Quirke et al., 1979) causes
ovulation of the preovulatory follicle and onset of luteinization (Warbritton, 1934;
McClellan et al., 1975; Parry et al., 1980; Murphy, 2000). Luteinization is the
morphological and biochemical remodeling process that forms a transient organ known
as the corpus luteum (CL) (Murphy, 2004).
Fabricius (1604) and Adelmann (1672) first described the CL as “numerous little
glands” on the porcine ovary. Research on the CL has focused on three main stages:
growth (luteinization), maintenance, and regression (luteolysis) (Murphy, 2000). The
most important hormone in reproduction and the hormone secreted from the CL in the
largest amount during the maintenance phase is progesterone (Murphy, 2000; Sangha et
al., 2002). Large luteal cells in the CL are responsible for secretion of the majority of
progesterone of the ewe (Fitz et al., 1982).
Oxytocin was first discovered by Sir Henry Dale (1906) when he found that
human posterior pituitary glandular tissue contracted the uterus of a pregnant cat. Dale
named this neuropeptide “oxytocin” meaning swift birth (Viero et al., 2010). Oxytocin is
produced not only in the hypothalamus and delivered via the posterior pituitary gland (du
Vigneaud 1956; Viero et al., 2010), but also in large luteal cells of the CL (Wathes and
Swann, 1982). Receptors for oxytocin have been localized in the uterus (Soloff et al.,
1979); endometrium, myometrium (Roberts et al., 1985; Sheldrick & Flint, 1985; Ayad &
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Wathes 1989), oviduct (Ayad et al., 1990) and cervix (Ayad et al., 1991). Receptors have
been found recently on small luteal cells of the CL in the ewe (Niswender et al., 2007).
Hence, researchers have studied effects of oxytocin on estrous cycle length, secretion of
progesterone by the CL and luteolysis.
Armstrong and Hansel (1959) reported that treatment, depending on the stage of
the cycle with oxytocin had an effect on estrous cycle length in the cow. Daily injections
initiated before day seven shortened the diestrous phase of the cycle. However, if daily
injections began after day 15, the estrous cycle and continued unabated beyond estrus, the
subsequent cycle was shortened. Milvae and Hansel (1980) found that giving
subcutaneous injections of oxytocin on days four through six reduced jugular
concentrations of progesterone on day eight.
In an attempt to investigate further the effects of oxytocin on the CL, Mankey
(2009) examined the effects of a combined oxytocin and vasopressin 1A receptor
antagonist, atosiban, on the response of the ovine CL to exogenous prostaglandin F2!.
Atosiban was delivered directly into the CL via a mini-osmotic pump. None of the four
doses ( 0.25, 1.25. 2.50 or 5 µg/h ) of atosiban altered the response of serum progesterone
to an injection of PGF2! or affected the weight of CL treated with PGF2! or vehicle
when compared to reference ewes. However, concentrations of progesterone before
treatment with PGF2! appeared to be reduced. In a subsequent experiment,
concentrations of progesterone were decreased during the 48-hour sampling period when
5 !g/h of atosiban was delivered continuously by the mini-pump. Hence, the first
objective of this study was to determine if a series of four bolus intravenous injections of
atosiban would affect serum progesterone in the mid-luteal phase ewe. The second
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objective was to determine if there was a dosage effect on serum progesterone when 0, 5,
10, or 20 mg of atosiban were injected intravenously. If atosiban were effective by the
systemic route, a further objective was to examine changes in other hormones (LH and
PGF2!) and genetic changes in the CL.
Review of Literature
Luteinization
Luteinization can be described as a morphological and biochemical
remodeling process that ensues after rupture of the preovulatory follicle and forms a
transient ovarian organ known as the corpus luteum (CL) (Murphy, 2004). In this highly
specialized process, two steroidogenic luteal cells are formed in response to the ovulatory
stimulus (Warbritton, 1934; Murphy, 2000) from two endocrine cells in the follicle:
granulosal and thecal cells. The granulosal cells are derived from mesothelial cells
originating from the ovarian surface epithelium during embryonic formation of the
ovarian follicles and become the large luteal cells (Juengel et al., 2002), which are
generally spherical when viewed histologically. Corner (1937) established that granulosal
cells were an integral part of the CL. The thecal cells, steroidogenic cells of the theca
interna, become the small luteal cells, which are smaller in diameter (15.8 µm) compared
to large to (29.2 µm) luteal cells in the ewe (Rodgers et al., 1984) and are distinguishable
by a stellate appearance.
Although outnumbered by the theca-derived, small luteal cells, the large
luteal cells make up 25 to 35% of the volume of the CL (Nett et al., 1976; Rodgers et al.,
1984). The large luteal cells are typical secretory cells with features such as Golgi
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complexes, rough endoplasmic reticulum and secretory granules, and the small luteal
cells have an in-folded nucleus (Schwall et al., 1986). This description applies for sheep
(Warbritton, 1934), cattle (Meidan et al., 1990), and the ferret (Mead and Joseph, 1988). i
The theca of the follicle can be separated into two parts: theca interna and theca
externa. The theca interna contains the glandular thecal cells, connective tissue, and small
blood vessels; whereas, the theca externa is connective tissue and smooth muscle-like
cells that form the outer layer of the ovulating follicle (Warbritton, 1934). At ovulation,
the follicle collapses, and a rapid influx of blood vessels, originating in the thecal layer,
invade the antrum (Murphy, 2001). The granulosal cells of the developing follicle had
functioned as a fused cell through intercellular gap junctions (Van Niekerk et al., 1975).
Intercellular bridges are broken down during ovulation and reformed during luteinization.
Reynolds and others (1999) suggested that there is intercellular communication in the
luteal parenchyma based upon the expression of gap junctions during luteinization. In
domestic ruminants, remodeling of the granulosal cells is very important in the formation
and function of the CL. There is evidence that some of the small theca-derived luteal cells
differentiate into large luteal cells (Cran, 1983; Alila and Hansel, 1984; Farin et al.,
1986).
The processes of ovulation and subsequent luteinization occur in response to a
surge of luteinizing hormone (LH) released from the anterior pituitary by gonadotropinreleasing hormone (GnRH), which is released from the surge center of the hypothalamus.
The surge causes a number of morphological and biochemical changes in the ovulatory
follicle, such as an eight-fold increase in the volume of the granulosal cells by
hypertrophy, proliferation and migration of the thecal cells, and a shift in steroid
!
!

!

'!

synthesis from estradiol 17-" to progesterone (Warbritton, 1934; Donaldson and Hansel,
1965; McClellan et al., 1975; Parry et al., 1980; Murphy, 2000). Functional lutenization
of both granulosal and thecal cells increased basal cAMP, secretion of progesterone, and
involved morphological changes in the mitochondria in association with the increased
intra cellular P-450scc (Richards et al., 1986; Rodgers et al., 1986).
The two-cell, two-gonadotropin hypothesis proposed by Armstrong and
Dorrington (1977) has been greatly supported in the rationale of follicular steroid
conversion and production. In this proposal, the early steps of follicular steroidogenesis
take place solely in the thecal layer with the conversion of cholesterol to progesterone
and subsequently into androgens, more specifically androstenedione and testosterone.
Androgens diffuse into the avascular granulosa where, under the influence of folliclestimulating hormone (FSH), they are converted by cytochrome p450 aromatase
(Richards, 1980) to estrogens. The granulosal cells are remodeled by the differentiationdependent modification of the steroid pathway.
Steroid acute regulatory protein (StAR), the rate-limiting factor in steroid
synthesis, transfers cholesterol from the cytoplasm to the inner mitochondrial membrane,
where is it converted to pregnenolone via P450scc and 3"-hydroxysteroid dehydrogenase
(Stocco, 2001). Both StAR and 3B-hydroxysteroid dehydrogenase are highly upregulated
during luteinization and their presence decreases or practically disappears after CL
regression (Chedrese et al., 1990; Albrecht et al., 2001).
The combined shift in cells and proteins produces a shift of ovarian hormones.
Estrogens are the primary product from the growing and dominant follicles. During and
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after ovulation there is a shift in the product to progesterone. Secretion of progesterone
by the newly formed CL will be low during the first few days and elevated during the
mid-luteal stage of the CL (Lipsett, 1978), because of increased uptake of cholesterol, the
parent material for progesterone. The 3-hydroxy-3-methylglutaryl coenzyme A reductase
(HMG-CoA) limits an early step in the synthesis of cholesterol (La Voie et al., 1997).
Although present at all stages of the luteal cycle, HMG-CoA does not seem to be a major
factor in the synthesis of progesterone from cholesterol (Plotkin et al., 2002). Two other
sources of cholesterol are high-density lipoproteins (HDL), which are vital to rodents,
and the low-density lipoproteins (LDL), which are more important in most other species
(Murphy and Silavin, 1989). The receptors for lipoproteins are increased seven-fold
during formation of the CL and contribute to the increase in progesterone production by
the mid-luteal phase CL (La Voie et al., 1997, Rajapaksha et al., 1997; Li et al., 1998).
During luteinization, cholesterol is transferred to the Golgi apparatus by a bulk
cholesterol transfer protein know as Niemann-Pick, Type C1 protein (NPC-1) (Gevry et
al., 2002). Two other mediators in the delivery of cholesterol to the CL are metastatic
lymph node 64 protein (MLN-64) and StAR like-protein, which are located in the
endosomes (Zhang et al., 2002).
Corpora Lutea
Short (1977) reviewed the historical basis for depiction of the CL. De Graff was
distinguished most for his description of the Graafian follicle, but he also provided the
initial description of the CL. He described “globular bodies” that appeared on the ovary
of rabbits after coitus and remained until after parturition and which gave an indication
for the number of fetuses present (De Graff, 1672). Warbritton (1934) published data
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describing the cells that complete the CL in the ewe, but like other researchers during that
time, she did not know all of the exact functions of the gland.
The different stages of luteal maturity and differentiation bring about three
different colors that can be observed by the naked eye on the ovaries of an exercised
reproductive tract: red, yellow and white. Red is indicative of the corpus hemorrhagicum
or “bloody body” that is formed immediately after ovulation. Yellow is associated with
the functional CL; the gland was officially termed that, meaning yellow body. White
refers to the corpus albicans or “white body” seen after the regression of the corpus
luteum. The colors are attributed to Malpighi’s description of bovine ovaries in 1697
(Adelmann, 1966).
Up until 1886, many scientists believed that the CL was just a scar that developed
after ovulation. However, Knauer (1886) established through ablation-replacement
studies that the ovary was a gland of internal secretion. Beard (1897) and Prenant (1898)
hypothesized that the CL had specific functions in gestation, lactation, uterine
development, and secreted substances into the blood stream. This early hypothesis was
supported by Fraenkel (1903) and Magnus (1901), who isolated luteal hormones seven
years after the experiments conducted by Beard and Prenant. The major advances in the
field of reproductive physiology and more specifically luteal research came after the
development of radioimmunoassays (RIA) to detect hormones in blood serum or plasma
(Niswender and Midgley, 1970). The RIA was far more sensitive than the standard
bioassays that were used previously to measure hormones.
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Three different lifespans of CL have been identified: long, short, and ultra short
(Stouffer, 2006). The CL classified as long-lived would be those seen in canines; these
animals are monoestrous species that have a prolonged cycle that can last from 2 weeks
to 6 months (Rothchild, 1981; Concannon, 1986; Olson et al., 1989). In these species, the
functional life span does not differ if the CL originated in a fertile or non-fertile cycle.
Species with CL in this classification include dogs, wolves, foxes, skunks and cats
(Eckstein and Zuckerman, 1956; Asdell, 1964) along with roe deer, armadillo and
marsupials (Tyndale-Biscoe, 1973; Sharman, 1976; Hoffmann et al., 1978).
The ultra short-lived CL are characteristic of rodents (Hilliard, 1973; Freeman,
2006), in which a truly functional CL does not form unless mating occurs. Rodents do not
have a true luteal phase and have estrous cycle lengths around 4 or 5 days. Females
become pseudopregnant and keep the CL functional for 10 to 13 days when true
pregnancy did not occur in response to mating (Gibori et al., 1988; Bowen-Shaver and
Gibori, 2004).
The focus of this review will concentrate on the short-lived CL, which occurs in
polyestrous species, animals with frequent ovarian cycles such as primates and human
beings. The lifespan of the CL is finite, around two weeks in those species, but is
prolonged if pregnancy ensues. In primates, if fertile insemination occurs, this extended
period allows for movement of the embryo into the uterus where it beings to implant
(Stouffer and Hearn, 1998). A similar sequence of events occurs in ungulates, which
include the domesticated farm animals such as cattle, sheep and goats. In this case, the
CL forms rapidly after ovulation and will continue to function until days 15 to 21
postestrus (Hansel et al., 1973; Goodman and Inskeep, 2006). If fertile insemination does
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not occur, the functional CL will undergo luteolysis, and the estrous cycle will be
repeated again. In the ungulates, follicular growth occurs during the luteal phase of the
estrous cycle (Fortune, 1994). This early growth allows for rapid follicular growth after
luteolysis, leading to another ovulation within two to three days. In contrast, the primate
has less opportunity for antral follicle growth during the luteal phase, and subsequent
ovulation and luteinization require about two weeks for the next ovulatory follicle to
emerge (di Zerega and Hodgen, 1981; Zeleznik, 2001).
After completion of luteinization, two types of steroidogenic cells play vital roles
in the secretory function of the CL. In addition to the large and small steroidogenic cells,
there are other cell types that play an important role in the CL, including endothelial
cells, smooth muscle cells, macrophages, leucocytes and pericytes (Alila and Hansel,
1984). The CL secretes multiple hormones. Progesterone is the most recognized steroid
hormone, along with small amounts of estradiol 17" in the case of sheep (Sangha et al.,
2002). The CL produces prostaglandin F2!, a hormone that plays a large part in
luteolysis, and peptide hormones, including oxytocin, vasopressin, inhibin and relaxin
(Fields, 1991).
Small and large luteal cells can be differentiated by immunocytochemistry and
histochemistry (Fritz and Fitz, 1991; Sharma and Sharma, 1998). Large luteal cells
represent approximately 40% of the volume of the CL in the goat, 33 to 38% in the sheep
and 40% in the cow. Large luteal cells are around 10% of the total cell numbers in the CL
in the goat, 8 to 14% in the sheep and 3.5% in the cow (Meyer, 1991). The large luteal
cells in the ewe are characterized by a nucleus that contains a nucleolus and euchromatic
nucleoplasm (Hoyer et al., 1988). With regard to small luteal cells, 18 to 23% of the
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volume of the CL in the sheep is made up of these cells, around 20% in the goat and 28%
in the cow. Of the total cell numbers, 23 to 36% are small luteal cells in the sheep,
approximately 25% in the goat and 26% in the cow (Farin et al., 1986; Fields and Fields,
1996; Sharma and Sharma, 1998). These small luteal cells contain smooth endoplasmic
reticulum and mitochondria; however, they lack rough endoplasmic reticulum and
secretory granules (Rodgers and O’Shea, 1982). The large luteal cells in the mature CL of
the sheep have a 1.8-fold greater frequency of mitochondria per unit volume of cytoplasm
compared to the small luteal cells; this indicates a higher metabolic investment in
differentiation and development (Kenny et al., 1989). In addition, the large luteal cells are
spherical (22 to 50 µm), and the small luteal cells are polyhedral, 12 to 22 µm in diameter
(Rodgers and O’Shea, 1982; Singh and Prakash, 1988; Sharma and Sharma, 1998). In
sheep, the newly-formed CL weighs as much as 600 to 700 mg in just a few days (Farin
et al., 1986; Jablonka-Shariff et al., 1993). Steroidogenic activity can be related to the
increase in the luteal cell diameter and will increase from days 6 to 8 and remain fairly
constant until day 15, when regression (luteolysis) will begin (Cunningham et al., 1975;
Juengle et al., 1993).
In the cow, luteal cell types have been termed type I and type II (Greenstein et al.,
1958) relative to their expected functionality. Experiments have been conducted to
characterize further the two steroidogenic cell types in the ovine CL. The most
outstanding difference in cell type is the diameter, which has been acknowledged in
numerous species, including the cow and the sheep. Small and large cells were identified
in the ewe (Priedkalns et al., 1968) and cow (Ursely and Leymarie, 1979; Koos and
Hansel, 1981).
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In an early study, Fitz and others (1982) looked at the differences in the two cell
types in the ewe. Ewes that were superovulated with human chorionic gonadotropin
(hCG) were used in this experiment, and 5 to 17 corpora lutea per ewe were removed by
midventral laparotomy. The tissue was sliced into 0.5 mm sections and was separated on
a Beckman JE-6 elutriator rotor, equipped with a Sanderson chamber, into 4 separate
fractions. Small luteal cells were contained mostly in fractions 2 and 3, and fraction 4
was limited to predominately large luteal cells. The cells were analyzed for the rate of
secretion of progesterone, number of specific binding sites and responsiveness to
LH/hCG, N6,O2-dibutyryladenosine 3’-5’-cyclic monophosphoric acid (dbcAMP), and
prostaglandins E2 and F2! (PGE2 and PGF2!). The secretion of progesterone was 20-fold
greater in the large luteal cells than in the small luteal cells without stimulation. However,
the responses to LH and dbcAMP in the small luteal cells were greater when compared to
the large luteal cells. Large luteal cells had 3,074 receptors for LH/hCG and the small
luteal cells had 33,260 receptors; whereas, the receptor sites for prostaglandins E2 and
F2! were localized mostly in the large luteal cells (68,143 F2! and 10,995 E2). In
contrast, the small luteal cells contained only 2,115 receptors for prostaglandin F2! and
904 for prostaglandin E2. The results demonstrated a clear-cut distinction between the
large and small luteal cells in the ovine CL. Progesterone appeared to be secreted
generally by the large luteal cells and seemed to be independent of LH. The small luteal
cells secreted small amounts of progesterone; however, they responded dramatically to
LH or dbcAMP (Fitz et al., 1982).
Progesterone secretion during late luteal phase of the estrous cycle is independent
of LH, although LH receptors are present on both large and small cells of the ovine CL
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(Rodgers et al., 1984). McNeilly, Crow and Fraser (1992) looked at the effect of a
gonadotropin-releasing hormone (GnRH) antagonist on episodic progesterone secretion
or CL function in ewes. Scottish Blackface ewes were treated intra-muscularly with a
GnRH antagonist at a rate of 1 mg per kg of body weight on day 4 or 11 of the luteal
phase. Blood samples were collected at 10- or 15- minute intervals between 0 and 8, 24
and 32, and 48 to 56 hours after the GnRH antagonist and daily from estrus for the
duration of the 22-day treatment. Treatment with the antagonist beginning on day 4 of the
luteal phase had no effect on luteal function until days 11 and 13, when progesterone was
lower than the controls. Concentrations of FSH were unchanged by antagonist treatment
on day 4 or day 11; however, no pulses of LH occurred in the treated ewes during the
administration of the antagonist, and LH was suppressed for 3 days post treatment. The
findings demonstrated that progesterone is released in an episodic manner from the CL
and is independent of the secretion of LH until day 11. Suppression of LH for 3 days did
not play a role in progesterone secretion or induce premature luteolysis (McNeilly et al.,
1992).
Mechanisms that control the ovine CL were investigated in 1973 by a group of
researchers in England and France with regard to DNA/RNA content, tissue weight and
concentration of progesterone in ovarian venous blood (Denamur et al., 1973). Ewes
were between 12 to 14 months of age and were hysterectomized on days 9 to 12 of the
estrous cycle. Twenty-seven animals were euthanized 27, 60, 128 and 135 days after
hysterectomy. The fresh weight of the luteal tissue, content of DNA, RNA and the
concentration of progesterone in ovarian vein blood were determined. In the other ewes,
hypophysectomies were carried out 20 to 50 days after hysterectomy. Two different
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techniques were used to remove pituitary function; the first technique was a complete
removal of the gland, and the other technique was to section the pituitary stalk and
remove the adjacent pars tuberalis tissue. In hysterectomized ewes that received cortisol,
(n = 37), CL were removed and studied at 24, 48, 72, or 96 hours or 12 days after
hypophysectomy. Ewes in a second group (n = 84) were hysterectomized and were given
cortisol daily following hypophysectomy; ewes in this group received FSH, LH, LH
+FSH, prolactin + FSH, prolactin + LH or prolactin + FSH + LH by intramuscular
injections or continuous intravenous infusion for 12 days.
Following hysterectomy alone, weight of the CL remained constant until day 60
and decreased by days 128 and 135 along with DNA and RNA. The progesterone content
in the CL demonstrated that CL function was still maintained after hysterectomy through
day 135. In ewes in which the pituitary was removed completely or the pars tuberalis was
destroyed, the results differed among treatments. When the pituitary was removed,
weight of the CL began to decline within 24 hours and continued to decrease rapidly for
three days, then leveled off between days 3 and 12. Progesterone followed the same
pattern in that the amount declined within 24 hours and by 72 hours was 5 to 7% of the
controls. In ewes in which the pituitary stalk was removed and the pars tuberalis was
destroyed, concentrations of progesterone, DNA and RNA and CL weight were not
different than observed in the hypophysectomized ewes. Injections of prolactin (250 to
1000 i.u/day) maintained the CL for 12 days after hypophysectomy, while 50 i.u/day was
unable to maintain the CL. Combination treatments of .25/.5 mg of LH + prolactin were
luteotrophic and increased the weight of the CL; however, other combinations did not
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increase CL weight. Therefore, both prolactin and LH were considered necessary for the
maintenance of the ovine CL.
However, Kaltenbach and others (1967) challenged the findings of Denamur’s
group. They found that FSH, prolactin or estrogen did not demonstrate luteotrophic
properties in hypophysectomized ewes and only constant infusion of crude LH
maintained the CL. In incubated ovine luteal tissue, only the addition of LH increased
progesterone concentration. The addition of FSH or prolactin had no effect on
progesterone synthesis (Kaltenbach et al., 1967). Both groups concluded that pituitary
support is necessary throughout the estrous cycle to maintain a functional CL
(Kaltenbach et al., 1968).
The general actions of progesterone secreted by the CL are important to the
maintenance of pregnancy. Progesterone acts on the reproductive tract to calm and
prepare it for initiation and maintenance of pregnancy. The effects of progesterone are
mediated through ligand-inducible transcription factors (Moutsatsou and Sekeris, 1997).
Ligands control the expression of genes by binding to response elements on the DNA and
previous exposure to estrogen induced the production of receptors for progesterone
(Kraus and Katzenellenbogen, 1993; Kaneko et al., 1993; Ing and Tornesi, 1997).
Progesterone receptors are required for progesterone to act on the reproductive tract. One
action of progesterone is to down regulate the receptors for estradiol, thus blocking the
mitogenic actions of estrogen (Brenner et al., 1974; Simpson et al., 1987; Fairchild and
Pate, 1989; Kraus and Katzenellenbogen, 1993; Iwai et al., 1995; Ing and Tornesi, 1997).
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During the follicular phase of the cycle, progesterone inhibited mitosis of the
endometrium by blocking the estrogenic effect of inducing proliferation (Cummings and
Yochim, 1984; Padykula et al., 1989). Progesterone also induced myometrial quiescence
by increasing the resting potential and preventing coupling of the myometrial cells, which
down regulated the voltage dependent calcium channels (Barta, 1986; Sharma and
Buetter, 1993). Myometrial contractions are limited via progesterone blocking the ability
of estradiol to induce !-adrenegic receptors (Bottari et al., 1983).
Regulation of progesterone
Gap junctions play a role in the regulation of progesterone secretion by ovine
luteal cells. Gap junctions are contact-dependent pathways within the CL that are thought
to be essential for the maintenance of the normal luteal tissue (Redmer et al., 1991; Del
Vecchio et al., 1994; Redmer & Reynolds 1996 and Grazul-Bilska et al., 1997a, 1997b).
Gap junctional intracellular communication is involved in many intracellular processes,
including exocrine and endocrine signaling. Gap junctions facilitate transport of nutrients,
ions and regulatory molecules between adjacent cells. Gap junctions play a role in
regulation and coordination of luteal cells (Grazul-Bilska et al., 1997a , 1997b, Sohl &
Willecke, 2004), and respond to systemic and local regulators of luteal tissue such as
cytokines, second messengers, hormones and growth factors (Grazul-Bilska et al., 2001).
LH and dbcAMP increase the rate of gap junctional intercellular communication between
luteal cells and progesterone secretion (Redmer et al., 1991). The major connexin
expressed within luteal cells during the estrous cycle is Cx43, which is localized in the
borders of the luteal cell and forms gap junctional channels for the intercellular
communication (Grazul-Bilska et al., 1997a,b).
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Borowczyk and coworkers (2007) collected ovaries from superovulated ewes to
obtain multiple CL per ewe. The ovaries were dissected, and corpora lutea were removed
for testing in culture. These authors looked first at four concentrations of steroidogenic
cells and their response to LH or dbcAMP. The CL was incubated for 24-hours, and the
medium was collected and assayed for progesterone. Contact dependent gap junctional
intercellular communication was determined by using a fluorescent dye and interactive
laser cytometry. Immunohistochemistry was conducted to identify steroidogenic cells.
The rates of gap junction intercellular communication and Cx43 mRNA expression were
affected by the day of the estrous cycle, cell density and treatment. Progesterone
secretion changed with changes in Cx43 mRNA expression, and the rates of gap
junctional intercellular communication. The Cx43 mRNA was identified on the borders
of all the luteal cells. These results demonstrated a positive correlation between
progesterone secretion and Cx43 mRNA expression and gap junctional intercellular
communication of luteal cells and that gap junctions are involved in steroidogenesis of in
ovine CL (Borowczyk et al., 2007).
The effect of progesterone on estrous cycle length is very important. In the
follicular phase of the cycle, concentration of progesterone is relatively low, whereas the
concentration of estrogen is relatively high. Increasing concentrations of estradiol 17-"
act via the hypothalamic-pituitary gonadal axis to stimulate low-amplitude, highfrequency pulses of LH, which drive the Graffian follicle to ovulate (Lucy et al., 1992).
After development of the CL, progesterone reduces the frequency of LH pulses and
blocks the surge of GnRH from the hypothalamus (Attardi et al., 1992; Kawai and Clark,
1986). The ovine CL secretes progesterone throughout the luteal phase until around day
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15 or 16, when secretion decreases as a result of luteolysis and the cycle will be repeated
with a new ovulation.
Luteolysis
Luteolysis is the cyclic regression of the CL and is caused by the episodic
secretion of uterine PGF2!. This secretion can act locally on the CL or via systemic
circulation (McCracken et al., 1999). Prostaglandin F2! is the major luteolytic hormone
in sheep (McCracken et al., 1972) and is released from the uterus with small peaks
recorded on day 12 and subsequent declines in progesterone (Scaramuzzi et al., 1974;
Baird et al., 1975; Ottobre, 1979).
Sharma and Fitzpatrick (1974) investigated the effect of estradiol-17" on
prostaglandin F2! secretion in the anestrous ewe. Clun Forest ewes were assigned to four
groups; each ewe received an intramuscular injection of estradiol-17" followed later by
intravenous injections of oxytocin in two doses separated by one hour. The amount of
estradiol varied among groups with group 1 receiving 0 µg, group 2, 50 µg and groups 3
and 4, 1 mg. Oxytocin was given in paired doses of 0.4 followed by 2 units for groups 2
and 3, or of 2 followed by 10 units for groups 1 and 4. Oxytocin was administered 24hours after estradiol injection. Posterior vena caval blood samples were collected every 6
hours from 3 days before estradiol injection to 24 hours after and every 5 minutes for 30
minutes and once again at 60 minutes after each oxytocin injection. Estradiol pretreatment increased concentrations of prostaglandin F2! in response to oxytocin.
Oxytocin had no effect on concentrations of prostaglandin F2! when administered alone;
however, in estradiol pre-treated ewes, a marked release of prostaglandin F2! occurred
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within 5 minutes after the oxytocin injection, followed by a decline to low concentrations
within 20 to 25 minutes post injection. When a second dose of oxytocin was administered
an hour later, no further increase in the production of prostaglandin F2! occurred. The
authors suggested that estrogen potentiated oxytocin-induced release of prostaglandin
F2! from the uterus and that these injections may completely empty the prostaglandin
F2! storage in the uterus, which may not be replenished within one hour (Sharma and
Fitzpatrick, 1974).
Cooke and Ahmad (1994) conducted an experiment to determine if prostaglandin
F2! induced the release of oxytocin from ovine CL in vitro. Luteal tissue was retrieved
from euthanized Welsh Mountain ewes on day 6 or 12 after observed estrus, sliced and
weighed. The tissue was preincubated for 45 minutes or 6 hours and then incubated for
60 minutes in PGF2!. Six different concentrations of PGF2! ( 0, 1, 10, 100, 1000, or
10000 nM ) were added to incubated tissue. The day-12 CL did not demonstrate a
different response to the varying amounts of PGF2! or the length of the preincubation. In
the day-6 CL, oxytocin was secreted in a dose dependent manner as the concentration of
PGF2! increased. If incubation was extended the luteal cells secreted more oxytocin. The
increased secretion of oxytocin from the day-6 CL supported the suggested hypothesis
that more oxytocin was secreted during mid-cycle in the CL (Cooke and Ahmad, 1994).
The ultrastructure and function of ovine CL in response to PGF2! treatment were
investigated by Umo (1975). Ten Clun Forest ewes were detected in estrus by a
vasectomized ram; the day the ewes were marked was designated as day 1 of the estrous
cycle. Saphenous vein catheters were placed in all the ewes on day 9, and blood samples
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were collected twice daily before 6 ewes were treated with 10 mg PGF2! i.m. on day 10,
four times after the treatment at 3-hr intervals and once on the day after removal of the
CL. The remaining ewes served as controls and received vehicle alone. Samples were
assayed for concentrations of progesterone. The dose of PGF2! used had been found to
be luteolytic (Douglas and Ginther, 1973). Twelve hours after the PGF2! injection, the
ovaries of the ewes were removed and the CL were dissected and fixed. Histological
slices were placed on wax. The ovaries of the control ewes were removed on day 15, and
both control and treated ovaries were fixed for electron microscopy. Mean concentrations
of progesterone fell from 4.8 + 0.2 ng/ml the day before treatment to 1.3 + 0.4 by 6 hours
after PGF2! treatment, and continued to fall to 0.5 + 0.4, 12 hours after the injection of
PGF2!. In ewes treated with PGF2!, there was an accumulation of lipid droplets and a
decrease in the amount of smooth endoplasmic reticulum. A change in shape of the
mitochondria and a decrease in the number of membrane-bound granules also were noted
in the PGF2!-treated group (Umo, 1975).
Oxytocin
Oxytocin is a central nervous system neuropeptide containing nine amino acids
that was first discovered in 1906 by Sir Henry Dale, who found that human posterior
pituitary glandular tissue extract contracted the uterus of a pregnant cat. With this new
knowledge, he named the neuropeptide “oxytocin,” for swift birth (Viero et al., 2010).
Vincent du Vigneaud was the first to sequence a peptide hormone, oxytocin, in 1953, and
for his laboratory work was awarded the Nobel Prize in 1955 (du Vigneaud, 1956). This
nonapeptide has been viewed as a hypothalamic neuropeptide that is released into
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circulation via the neural lobe of the pituitary and in turn induced uterine contractions
during parturition and milk ejection during lactation. Oxytocin is the strongest uterotonic
agent known and is commonly used to induce labor. An antagonistic analog to oxytocin,
atosiban, is currently used to prevent preterm uterine contractions in women; that effect
reflects the role for oxytocin in human labor (UKMi, 2001).
Oxytocin has other roles in the reproductive and social behaviors than just
inducing uterine contractions. These roles include mediating social behaviors (Young et
al., 1998), maternal behavior, sexual receptivity, and partnership bonding, so that some
have concluded that oxytocin could be termed the “love hormone.” Oxytocin receptors
are expressed in the pituitary, kidney, ovary, testis, heart, thymus, vascular epithelium,
osteoclasts, cancer cells, adipocytes, myoblasts and pancreatic islet cells (Gimpl &
Fahrenholz, 2001).
The proposed actions of oxytocin are all mediated through a single oxytocin
receptor. The receptor is a seven transmembrane receptor and is a member of the class 1
family of G protein-coupled receptors (Gimpl & Fahrenholz, 2001). These protein
receptors include three vasopressin receptor subtypes, ( V1a, V1b, V2 ) and the oxytocin
receptor. That forms a subfamily of structurally closely related receptors. The members
of this family, with exception of the V2 receptor, bond with Gq/11 and activate
phospholipase C in response to agonist binding (Ku et al., 1995).
During late gestation, the expression of the oxytocin receptor in the uterus is up
regulated two fold, which results in a strong increase in uterine sensitivity to oxytocin
(Soloff et al., 1979). After parturition, uterine oxytocin binding sites undergo a rapid
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decrease; however, oxytocin receptor expression in the mammary gland expression
remained increased throughout lactation (Soloff et al., 1979; Brenton et al., 2001). Tissue
specificity allows circulating oxytocin to target organs and specifically to induce milk
ejection during lactation and uterine contractions during parturition.
Both ovine and bovine luteal cells synthesize oxytocin via a precursor protein
similar to a protein found in the hypothalamus. Swann and colleagues (1984) collected
bovine CL 5 to 10 days post-ovulation and sheep CL 3 days post-ovulation. The cells
were isolated and incubated, and the hormones were detected using RP-HPLC. Oxytocinrelated components were isolated by immunoprecipitation with anti-oxytocin antiserum.
Oxytocin was positively identified, via HPLC, as the hormone secreted by the ovine and
bovine cells. Also, ovine cells appeared to synthesize more hormone than the bovine cells
(Swann et al., 1984). Circulating concentrations of oxytocin and the patterns of its release
vary during different stages of the estrous cycle. During the first 4 days after estrus,
circulating oxytocin is low; at this time oxytocin stores in the old CL have been depleted,
and synthesis is reinitiated in the preovulatory follicles (Wathes et al., 1993). Oxytocin
release from the posterior pituitary can occur during this time of the cycle. These pulses
have a duration of about 2 minutes at a frequency of 3 per hour (Gilbert et al., 1991).
Oxytocin gene expression in the developing CL increases around the time of luteinization
and release of oxytocin into circulation increases at this time. The concentration of
oxytocin in CL rises between days 3 and 9 of the estrous cycle. In the ewe, concentrations
of oxytocin increased until day 10, and a decrease was noted on that day (Jones et al.,
1988; Ivell et al., 1990). However, the concentration of oxytocin began to rise again
around day 14 to 15 as luteolysis was underway; at this stage estrogen is rising and
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endometrial oxytocin receptors are detected, allowing establishment of a positive
feedback loop between the uterus and the ovary. Oxytocin-induced the release of
prostaglandin F2! from the uterus, which, in turn, stimulated the release of oxytocin from
the regressing CL (Flint and Sheldrick, 1983).
Use of iodinated oxytocin receptor antagonists allowed researchers to localize
binding sites in the reproductive tract. Endometrium, myometrium (Roberts et al., 1985;
Sheldrick and Flint, 1985; Ayad et al., 1984), oviduct (Ayad et al., 1990) and cervix
(Ayad et al., 1991) all contain high affinity binding sites for oxytocin. There are low
affinity binding sites in the ovary. Reports based on the human oxytocin receptor
sequence supported the hypothesis that binding of oxytocin to its receptor activated a Gprotein that signals through calcium channels. The resultant stimulation of
phospholipase-C increases turnover of inositol phosphates (Flint et al., 1986; Ott et al.,
1992). Increased turnover of inositol phosphate breaks down diacylglycerol to fatty acids,
such as arachidonic acid, which is the rate-limiting precursor of prostaglandin F2!
production. Thus, increasing availability of fatty acids, more specifically arachidonic
acid, allows for PG-synthase to convert arachidonic acid to prostaglandins, and increased
secretion of PGF2! can be measured by its metabolite 13,14-dihydro-PGF2! (PGFM).
Oxytocin injections to cyclic ewes during the early and mid-luteal phase had no effect on
PGFM. However, if oxytocin was injected on days 14 to 16 when estrogen was greater,
an increase in PGFM was observed, with the maximum response to an injection on day
15 (Fairclough et al., 1984; Silvia et al., 1992).
Further research was conducted to determine if oxytocin receptors are located in
the cervix of the ewe changed during the estrous cycle. Cervical smooth muscle was
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removed from the reproductive tract of 26 ewes during different stages of the estrous
cycle, and the concentration of oxytocin receptors was determined by binding to 5 nmol/l
oxytocin. Higher amounts of oxytocin receptors were found in cervical tissue only after
day 15, and it peaked on the day of estrus (Matthews and Ayad, 1991).
Portions of the reproductive tract were challenged with oxytocin at different times
of the estrous cycle while recording electromyographic (EMG) activity. Oxytocin
injected intravenously at 25, 50 and 100 mU resulted in mean peak plasma oxytocin
concentrations of 2.2, 6.4 and 8.6 pg/ml with the values returning to baseline within 10
minutes. Observed concentrations were similar to peaks occurring during a natural
estrous cycle. The same procedure was conducted on ampulla, ampullary-isthmic
junction, uterotubal junction, uterine horn, uterine body and cervix. The lowest dose of
oxytocin, given at estrus, stimulated a response in all regions. Following estrus, the
activity of the cervix and uterus was depicted by a coordinated muscle contraction that
started at the cervix and proceeded to the uterotubual junction every 40 minutes. Thus,
pituitary released oxytocin may regulate reproductive tract activity and could influence
gamete and/or embryo transport (Garcia-Villar et al., 1982; 1983).
Knowledge of actions of oxytocin in the ovary progressed rapidly after finding
ovarian oxytocin receptors in several species. In nonpregnant women, oxytocin-binding
sites (Fuchs et al., 1990) and oxytocin receptor mRNA (Kimura et al., 1992) were at the
highest concentration in late luteal phase. Oxytocin positive staining in the ovarian
stroma and theca interna was maximal during diestrus (Zhang et al., 1991). In the cow
ovary, oxytocin staining was found in the stroma and CL with peak concentrations
around the time of luteolysis (Fuchs et al., 1990). Concentrations in the CL were highest
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during mid-estrous cycle (Okuda et al., 1992). Oxytocin binding to luteal membranes and
ovarian stroma was low throughout the estrous cycle in sheep (Wathes et al., 1992).
Oxytocin is synthesized by the large cells of ovine CL (Rodgers et al., 1983;
Jones and Flint 1988), and secretion is described as pulsatile during the luteal phase of
the estrous cycle (Wathes, 1989). Swann and others (1984) demonstrated that bovine and
ovine luteal cells synthesize oxytocin. The purpose of their experiment was to
demonstrate how the luteal cells synthesize oxytocin by way of a precursor protein
similar to one found in the hypothalamus. Bovine and ovine CL were collected, isolated
and incubated with s-cysteine. Column separation and reverse-phase high performance
liquid chromatography were used to determine the presence of oxytocin in luteal cell
extracts. Less than 2 hours of incubation were required to recover labeled oxytocin and
vasopressin. However, longer incubation showed peaks of radioactivity of both
hormones. The results indicated that biosynthesis of luteal oxytocin involves the
formation of a 14-kDA precursor protein that is cleaved to form oxytocin and
neurophysin. Vasopressin was found in luteal tissue of both species, however, in smaller
amounts when compared to oxytocin (Swann et al., 1984).
Many conflicting roles and suggestions about oxytocin have been offered.
Cultured luteal cells have provided inconsistent results, and microdialysis systems have
provided a different insight into the roles of oxytocin. Exogenous oxytocin induced an
acute release of progesterone, and this release was blocked by the administration of an
oxytocin antagonist in the cow (Miyamoto and Schams, 1991). The response to oxytocin
was related to the availability of receptors and was maximal in early luteal phase (Fuchs
et al., 1990).
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Mitchell and others (1982) investigated the release of oxytocin during the ovine
estrous cycle, pregnancy and parturition in mixed-breed ewes. Daily carotid artery blood
samples were taken prior to beginning the experiment to determine the stage of the
estrous cycle of the nonpregnant ewes. Six pregnant ewes, fitted with a jugular catheter
and divided into three groups and sampled on days 122 and 124, at term pregnancy days
141 and 145 and during labor on days 146 and 148 of gestation. Of the two ewes in labor,
one lambed during the sampling period and the other delivered 6 to 12 hours after the
conclusion of the experiment. Oxytocin fluctuated acutely in the nonpregnant ewes
during the two time periods: during the follicular phase and the early luteal phase. The
pattern was more pronounced when the blood samples were collected at 1-minute
intervals; oxytocin in the follicular phase was 39.2 + 1.5 and 36.7 + 1.3 (pg/mL) and 68.4
+ 2.0 and 53.1 + 1.6 for the early luteal phase, with the differences between phases being
significant. In the pregnant group, the average concentrations of oxytocin (pg/mL) were
17 + 4, 8 + 3, 22 + 10, 22 + 8, 28 + 11, and 166 + 135, respectively, as gestation
progressed. The outlier in the group was the ewe that delivered during the experiment.
The authors concluded that the magnitude of oxytocin increased as the ewe approached
parturition (Mitchell et al., 1982).
Trophoblast interferons can suppress development of oxytocin and estradiol
receptors in the ovine endometrium. Interferon tau (IFN-t) signals maternal recognition of
pregnancy (maintenance of CL) in sheep and cows (Lamming et al., 1995). This
mechanism was investigated in Finn-Dorset ewes with one uterine horn isolated on day 6
or 7 of their estrous cycle. The ewes were mated to a fertile or vasectomized ram and
euthanized on day 13 or 16 after mating. On day 16, there was no measurable uterine
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INF-t in the isolated horn; however, concentration of oxytocin receptors were high in
both horns in ewes mated to the vasectomized rams. In ewes that conceived, a higher
concentration of oxytocin receptors was found in the isolated non-pregnant horn 585 +
131 fmol mg-1 compared to the pregnant horn that contained 45 + 11 fmol mg-1. The
pregnant horn expressed a significantly higher antiviral activity. Using in situ
hybridization and an oxytocin antagonist, large amounts of oxytocin receptor message
and binding sites were found in the endometrium of the isolated horn.
Immunocytochemical studies demonstrated that there was a suppression of estradiol
receptors in the pregnant horn when compared to the isolated horn. These findings
indicated that INF-t plays a role in suppression of development of oxytocin and estradiol
receptors in the endometrium of the pregnant ewe (Lamming et al, 1995). Further, INF-t
extended luteal life span in ewes, when infused into the uterine vein (Bott et al., 2010).
Other studies have demonstrated that oxytocin in the ewe increased after day 15,
and the peak concentration of oxytocin was on the day of estrus (Mathews & Ayad, 1991;
Ayad et al., 1991). These data led researchers to determine the role of progesterone and
estradiol 17" in regulation of uterine oxytocin receptors. Forty mixed breed ewes were
ovariectomized and randomly placed into 8 groups. Four treatments were vehicle (corn
oil) for 12 days, progesterone for 9 days, progesterone for 9 days followed by
progesterone withdrawal until day 12, and progesterone for 12 days. The second subset of
four treatment groups combined the effect of progesterone with estradiol 17-". Ewes
received an intramuscular injection of progesterone or vehicle on day 1 at 0700h and
1900h to mimic circulating progesterone concentrations in the mid-luteal phase of the
estrous cycle. Estradiol implants or blanks were implanted subcutaneously into the
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axillary region of the ewes. The ewes were euthanized on day 10 or 13. Two other ewes
were treated with an intravaginal sponge containing medroxyprogesterone acetate, and
before sponge removal the ewes were injected on day 11 with 100 µg of estradiol
subcutaneously. A second injection of estradiol was given on day 12, and the ewes were
euthanized on day 13 for tissue collection. Blood samples (10 ml) were removed via
jugular catheter daily at 1900h and the last sample was removed just before the ewes
were euthanized. The blood samples were analyzed for progesterone and estradiol via
radioimmunoassay.
Numbers of oxytocin receptors in the caruncular and intercaruncular endometrium
did not differ between the two treatments. When estradiol was not included in the
treatment with progesterone (9 or 12 days), concentration of the oxytocin receptors was
reduced, which was similar to the estradiol withdrawal group and the control group. The
presence of estradiol reduced concentrations of oxytocin receptor in the control and both
the 9- and 12-day continuous progesterone treated groups; however, it increased the
number of oxytocin receptors in the progesterone withdrawal group. These findings
supported past studies (Ayad and Matthews, 1991; Ayad et al., 1991) of the pattern of
oxytocin receptors during the natural estrous cycle in sheep with progesterone declining
at the time of luteolysis and estrogen increasing in preparation for the LH surge and
ovulation (Zhang et al., 1992).
Forty-five ovariectomized Merino ewes were given exogenous
progesterone and estrogen to mimic a normal estrous cycle (Lau et al., 1992). The
objective of this experiment was to determine the effect of prostaglandin F2! response
and concentration of endometrial oxytocin receptors in response to progesterone. The
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ewes were placed randomly into five treatment groups, group one served as a control,
group 2 was pretreated with progesterone and estrogen, group 3 was pretreated and given
progesterone for 12 days from day 1 with increasing doses of progesterone from 0.5 to 12
mg, group 4 was given PGF2! twice a day at different dosages with respect to the day;
0.5 mg on day 10, 1.0 mg on day 11 and 2.0 mg on day 12. The last group received both
progesterone and PGF2! at those times. In experiment 1, all ewes were given an
intravenous injection of 10 i.u of oxytocin at 0900 h on days 13 and 14 after estrus. The
concentration of the metabolite of PGF2! (PGFM) was measured when blood samples
were taken at -10, -5, 5, 10, 20, 30, 45 and 60 minutes around the time of the oxytocin
injection. In the second experiment, ewes were hysterectomized on day 14, and uteri were
analyzed for endometrial oxytocin receptors.
There was no detectable oxytocin-induced PGFM response to the steroid
pretreatment. On day 14, the progesterone treatment alone, and the progesterone and
PGF2!-treated groups each gave a significantly higher response when compared to the
control ewes. Binding data were derived by using a Scatchard analysis and indicated that
the highest concentrations of endometrial oxytocin receptors were in the untreated ewes.
Progesterone and estrogen pretreatment did not change the concentration of endometrial
oxytocin receptors; however, treatment with progesterone alone or in combination with
PGF2! lowered the concentration of receptors. These results translate that as PGF2!
increased, number of oxytocin receptors decreased (Lau et al., 1992).
Twelve heifers were fitted with a jugular cannula or an osmotic pump. Saline or
oxytocin were given by each route of administration. In a subsequent experiment, the
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heifers also received a challenge injection of oxytocin on day 16 of the estrous cycle. The
objective of the experiment was to determine if a constant infusion of oxytocin would
prolong the luteal phase and inhibit uterine prostaglandin F2! secretion in heifers. The
method of administration did not have an effect on estrous cycle length or the pattern of
progesterone secretion. However, the estrous cycle was significantly extended by
oxytocin administration 25.3 + 0.4 days compared to 20.5 + 0.4 days in the control group.
Luteolysis did not occur in oxytocin-treated heifers until the treatment had ended. In
experiment 2, the results were similar when comparing the length of the estrous cycle;
however, the challenge dose of oxytocin induced release of PGF2! in the saline-treated
heifers, but not in the oxytocin-treated heifers (Lutz et al., 1991).
Actions of oxytocin within the corpus luteum
Armstrong and Hansel (1959) looked at the effect of oxytocin on the CL and
progesterone production. Once daily injections of oxytocin during the first seven days
shortened the diestrus phase of the cycle; however, injections of oxytocin beginning on
day 15 and continued through their normal estrous cycle shortened only the subsequent
estrous cycle. Corpora lutea forming after the oxytocin treatments lacked size and
number of luteal cells, which lead to their diminished function. Three oxytocin injections
per day for the first ten days of the estrous cycle in heifers decreased the weight of the CL
collected on day 11 and also decreased serum progesterone concentrations (Simmons and
Hansel, 1964). Fairclough et al. (1984) found that at the end of the estrous cycle, pulses
of PGF2! were simultaneous with pulses of oxytocin, which this was also true with
exogenous injections of oxytocin (Silvia and Silvia, 1989).
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Other researchers have reported that oxytocin can function as a luteolytic agent.
Twice-daily subcutaneous injections of oxytocin on days four through six reduced jugular
progesterone levels by day eight in cattle (Milvae and Hansel, 1980a). However, when
comparing the concentrations of PGF2! in the uterine vein and ovarian artery, an increase
in concentrations of PGF2! occurred in the uterine vein 30 and 240 minutes after each
injection of oxytocin, but was not detected in the ovarian artery. The transport of PGF2!
from the uterine vein to the ovarian artery occurs by diffusion and takes 30 minutes
(McCracken et al., 1972; McCracken et al., 1981; Hixon and Hansel, 1974). However,
Milvae and Hansel (1980a) detected no local transfer of PGF2! from the uterine vein to
the ovarian artery in oxytocin-treated ewes. An oxytocin infusion caused an increase in
the concentration of PGF2! within 30 minutes in the ovarian arteries, which remained
stable for 15 minutes (Bonnin et al., 1999).
Vasopressin 1A
Arginine vasopressin and oxytocin are structurally related, with only two amino
acids sequences differing at the 3 and 8 positions, of a 20-membered ring. The primary
role for vasopressin is regulation of renal and cardiovascular function. Antiduretic actions
on kidney AVP-V2 receptors correct changes in blood osmolarity and its pressor actions
on vascular smooth muscle. AVP-V1a receptors help maintain peripheral résistance
under adverse conditions (Cowley, 1982; Kim et al., 1985). Hypothalamic arginine
vasopressin thought via V1b receptors stimulate adrenocorticotropic hormone release
from the pituitary (Antoni et al., 1984; Jard et al., 1986). Similar to oxytocin receptors,
vasopressin receptor subtypes are members of the G-protein-coupled superfamily
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(Kimura et al., 1992; Morel et al., 1992; Hirsawa et al., 1994; Thibonnier et al., 1994;
Rozen et al., 1995). Most arginine vasopressin V1a antagonists have been developed for
treatment of hypertension and congestive heart failure (Yamamura et al., 1991).
Nine multiparous Clun Forest pregnant ewes were used to determine the amounts
of oxytocin and vasopressin in blood plasma and cerebrospinal fluid (Kendrick et al.,
1990). Blood samples were taken by jugular venipuncture and cerebrospinal fluid was
taken from the lateral ventricle. Animals were induced into labor by an injection of
dexamethasone sodium phosphate (20 mg intramuscularly) on day 142. Three to five
samples were taken before contractions began, 3 to 4 samples during visible contraction,
and one sample immediately following the birth of the lamb and then at 15, 30, 60, 90
and 120 minutes post-partum. Six of the nine ewes were sampled three months post
parturition and 1 month after weaning. Ewes were given daily injections of estradiol
benzoate for 48 hours and sampled immediately after vaginocervical stimulation.
Stimulation consisted of rhythmically inserting and removing a plastic probe. Oxytocin
and vasopressin concentrations were measured by radioimmunoassay.
Concentrations of oxytocin in plasma and cerebrospinal fluid were significantly
greater during contractions and birth (4.28 pmol/l) than during preparturition (1.9 pmol/l).
Oxytocin concentrations were 2-fold greater in the cerebrospinal fluid than in plasma.
Plasma concentrations of vasopressin were significantly elevated during contractions and
birth, and for 15 minutes postpartum. After five minutes of mechanical vaginocervical
stimulation an increase of oxytocin and vasopressin was found in cerebrospinal fluid and
plasma (Kendrick et al., 1990).
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Atosiban and Barusiban
Atosiban (ATO) or Tractocile is a mixed (V1a) and (OT) receptor competitive
antagonist that has been developed for the treatment of preterm labor (PTL) contractions
(UKMi, 2001). Ferring Pharmaceuticals developed this synthetic peptide in 1985 with the
chemical structure being (1-deamino-D-Try(O-Et)-4-Thr-8-Orn)-Oxytocin) (Wellnitz et
al., 1999). ATO was the first tocolytic developed and approved in Europe (Reinheimer,
2007; Reinheimer et al., 2005), and it has been used with less adverse side effects, such
as tachycardia, vomiting, headache, chest pain, fetal tachycardia and tremors (Wex et al.,
2009), than the Beta-mimetic agents (UKMi, 2001; Heus et al, 2008, 2009). The
disadvantage of using ATO is the quick half-life and the rapid plasma clearance, with the
initial half-life being 13 + 3 minutes and the terminal half-life being 102 + 18 minutes.
The plasma clearance was 43 L/hr in human patients (Goodwin et al., 1995). ATO also
has been used in infertility treatments to decrease spontaneous uterine contractions that
could possibly expel in-vitro fertilized embryos that are transferred to women. Pierzynski
et al. (2007) infused ATO (6.75 mg bolus, 1-hour infusion at 18 mg/h and a 2-hour
infusion of 18 mg/h) during embryo transfer and successfully implanted two fertile
embryos that resulted in a pregnancy. The interpretation was that ATO efficiently
lowered the uterine contractions and allowed the embryos to implant instead of being
expelled (Pierzynski et al., 2007).
Another tocolytic is barusiban (FE 20040), which was developed in Copenhagen,
Denmark, by Ferring Pharmaceuticals. Barusiban has a 300-fold greater binding affinity
for the human cloned OT receptor than for the V1a receptor (Reinheimer et al., 2005)
compared to ATO. Barusiban is comparable to ATO in the lower amount of side effects
!
!

!

&%!

when compared to beta-mimetic agents. Reinheimer and others (2005) concluded that
both antagonists had a high efficacy, with 96 to 98% inhibition of intrauterine pressure in
OT-infused cynomologus monkeys. The onset of action and efficacy of each antagonist
were not different; however, the duration of action was significantly longer when
infusing barusiban compared to atosiban (Reinheimer et al., 2005). The half-life of b
arusiban was 1.5 to 2.6 h compared to the 0.5 to 0.7 hours for Atosiban (Reinheimer et
al., 2005).
Heus et al. (2008) found differences between treatment of ATO and ritodine in the
maternal blood pressure (MBP), maternal heart rate (MHR), intra-uterine pressure or fetal
heart rate (FHR). Ritodine-treated patients showed a rise in MHR while the MHR
remained unaltered in the ATO-treated group. There was no significant change in the
systolic or diastolic blood pressure in either group. The FHR rose in the ritodine group to
11.6 bpm compared to the 4.9 bpm in the ATO-treated group.
Reinheimer et al. (2007) completed the comparison between barusiban and
atosiban in the cynomologus monkey. Oxytocin was given to pregnant monkeys to
induce contractions and simulate pre-term labor. Atosiban and barusiban were
administered intravenously with bolus or infusion to investigate changes in the response
of the uterine contractions. Both antagonists had a high efficacy (96-98%) of inhibition of
intrauterine pressure and barusiban had a quicker response time being 3 to 4 times more
potent than atosiban.
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Statement of the problem
Research concerning ovulation, luteinization and mechanisms that control the CL
has lead researchers to investigate the effect of oxytocin on the CL, primarily in sheep
and cattle. Results from Armstrong and Hansel (1959) and Sheldrick et al. (1980) led
researchers at West Virginia University to investigate the role of oxytocin by treatment
with an antagonist directly on the ovine CL.
Mankey (2009) investigated the effects of atosiban, a combined vasopressin 1A
and oxytocin receptor antagonist, delivered by an osmotic mini-pump, on the function of
the ovine CL and the response to prostaglandin F2!. Atosiban, regardless of dosage, did
not alter the decrease in serum progesterone or weight of the CL after an injection of
PGF2!. However, progesterone appeared to decrease before the treatment with PGF2! in
ewes receiving atosiban. In a second experiment, progesterone concentrations were
decreased during a 48-hour sampling period when 5 !g/h of atosiban was continuously
delivered by the mini-pump, but progesterone in CL did not decrease.
The main objective of the current experiment was to determine the effects of
atosiban administered systemically. The first objective was to determine if atosiban
administered in four systemic bolus injections had an effect on concentrations of serum
progesterone and if the effect observed by Mankey was confirmed, to examine luteal
function in more detail. Blood samples were drawn from a posterior vena cava catheter
(Benoit and Dailey, 1991) every 15 minutes for 8 hours from mid-cycle (days 8 to 10)
ewes. Ewes were given four intravenous injections of 0, 5, 10 or 20 mg of atosiban.
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Material and Methods
The study was conducted in August and September 2010 on the West Virginia
University Animal Science Farm. A total of 24 non-lactating ewes of predominantly
Suffolk breeding were assigned at random to treatments. Ewes were fed corn silage
during the estrous detection period and prior to catheterization; after catheterization the
ewes were provided mixed grass hay until blood sampling. The experimental protocol
was approved by the West Virginia University Animal Care and Use Committee
(protocol number 08-0501).
Estrous detection began August 1 on a larger group of ewes (n = 36) and was
continued until cycles were recorded on a sufficient number of ewes to begin the
experiment. Ewes were housed in an open-sided research barn and were checked for
estrus twice daily with the use of vasectomized rams, fitted with a crayon marking
harness. A vasectomized ram was in constant contact with the ewes during the preexperimental period, and after ewes were marked, they were rechecked with another
vasectomized ram to confirm standing estrus. Ewes were required to exhibit a complete
estrous cycle of normal length (~16 days) prior to beginning the experiment. Ewes were
between days 8 and 10 post estrus at the time the experiment was initiated. Replicates
consisted of 5 to 8 ewes depending on the numbers observed in standing heat during a
two-day period. After allocation into treatment groups, posterior vena cava catheters were
inserted into the ewes at a depth of 65 cm. Ewes were then housed in a smaller pen and
provided with free choice water and mixed grass hay until the start of the treatments.
Blood sampling and treatments were initiated approximately 12 hours after catheter
placement.
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Ewes were haltered, secured to a fence in the barn period and offered water
halfway through the experiment. The blood sampling began one hour before treatment
and continued for nine hours, every fifteen minutes. Six mL of blood was obtained at
each time point, and the catheter was flushed with heparinized saline after each sample.
Blood was transferred from the syringe into a heparinized 13 x 100 mm disposable
sample tube (Fisher Scientific) and placed on ice until plasma was removed and placed in
15 x 45 mm sample vials (Fisher Scientific, ). Vials were stored in a -20 degree freezer
until further processing. Treatments consisted of four jugular injections of either 0, 5, 10,
20 mg of ATO, an hour apart over 3 hours (0, 1, 2 and 3 h). Atosiban was weighed out
one day prior to the experiment and dissolved into 3 mL of phosphate buffered saline
(PBS) for the treatment injections.
After blood sampling, the ewes were given one half hour to consume hay and
water and were then placed in a dry pen for preparation for ovariectomy (OVX). Ewes
were shorn and taken to the Food Animal Research Facility (FARF) for OVX; one final
blood sample was obtained prior to OVX at 24 hours after the first injection of ATO.
Ovaries were removed and the CL was excised and cut into four pieces and frozen. For
the OVX procedure, see Foradori et al; (2005); isoflurane was used instead of halothane
as an anesthetic. Ewes were observed during recovery, received post-operative antibiotic
treatments at the FARF and were returned to the research barn after 24 hours.
Radioimmunoassay was performed on all plasma samples (n = 37 per ewe) to
measure concentrations of progesterone. Intra- and inter- assay coefficients of variance
were 4.6% and 2.6% respectively. The standard curve ranged from 0.1 to 8.0 ng/mL, and
the sensitivity of the assay was 0.20 ng/mL. Values for progesterone ranged from 0.2 to
!
!

!

&)!

39.8 ng/mL, with most samples < 6 ng/mL. Indicating that even at 65 cm (Benoit and
Dailey, 1991 had used 56 cm in smaller ewes) the catheters were usually allowing
sampling of blood prior to entry of ovarian drainage into the posterior vena cava.
Statistics
Data for concentrations of plasma progesterone were analyzed using Proc
GLM procedure (SAS Institute; Cary, NC:9:2), with log10 transformation of progesterone
values to account for the heterogeneity of variance of the values. The model tested the
effects of dose of ATO, animal within dose, and the dose by time interaction. A dose by
time interaction was observed (P < 0.001); therefore, orthogonal contrasts were made of
the control (0 mg) to the treatments (5, 10, and 20 mg), the lower doses (5 and 10 mg) to
the high dose (20 mg) and the low doses (5 and 10 mg) to each other. Pre-treatment
progesterone values and end of experiment weights of CL were used as covariates in the
comparisons to adjust for the effects of those variables on progesterone values.
Comparisons were made separately during the treatment (time 0 to 240 minutes) (1 hour
after last treatment) and post-treatment from (greater than time 240 until the 24 h).
Results
Corpus Luteum Weight
Weights of CL from ewes treated with 5 or 10 mg of atosiban differed
significantly (P < 0.03). However, there was no significant difference between the mean
CL weights of the treated ewes to the control or 20 mg versus 5 and 10 mg doses
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(Figure 1).

Figure 1. Mean corpus luteum weight (± SEM) showing effect of atosiban. Bars
represent treatment group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There
were significant differences the between 5 and 10 mg dosages (P < 0.03).

Treatment phase effects on progesterone concentration
The concentrations of progesterone in the control ewes differed (P < 0.0001)
from ewes treated with 5, 10 or 20 mg of atosiban. In addition concentrations of
progesterone differed between the 20 mg dose and the 5 and 10 mg doses together (P <
0.05, Figure 2).
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Figure 2. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There was a significant
difference between ewes treated (5, 10 or 20 mg) with atosiban to control ewes (P <
0.0001) also when comparing the 20 mg dose to the 5 and 10 mg doses (P < 0.05).

Considered together, these comparisons show that there was a decrease in the
mean progesterone for ewes treated with 5, 10 or 20 mg of atosiban compared to the
control mean. However, when comparing the treatment groups, 10 and 20 mg of atosiban
decreased the mean progesterone concentrations when compared to the control and the 5
mg dose. The 10 and 20 mg dosages of atosiban were the most effective in lowering
progesterone concentration compared to the other treatments during this interval of the
experiment.
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Post treatment effects on progesterone concentration
There were differences during this time interval comparing the controls to all
treated groups (P < 0.005), and ewes treated with 20 mg versus 5 and 10 mg (P < 0.05,
Figure 3).

Figure 3. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There were significant
differences for control versus treatment (0 mg vs 5, 10 and 20 mg) (P < 0.005), and
between the high dose versus the lower dosages (20 mg vs 5 and 10 mg) (P < 0.05).

During this time interval the mean log10 progesterone concentration of the control
ewes decreased (1.04) compared to the treatment interval (1.07). There was an increase
(1.02 vs. 0.99) in the mean log10 progesterone concentrations of the ewes treated with 10
mg of atosiban. Values for the 5-, 10- and 20-mg-treated groups were lower than those in
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the control ewes during the post-treatment period. The lowest progesterone concentration
was seen in the group treated with 20 mg of atosiban.
Overall effect of dose on progesterone concentration
When analyzing the overall effect of atosiban on progesterone concentrations
from time 0 until the end of the experiment, there was a significant difference when
comparing the control ewes to the ewes treated with (5, 10 or 20 mg) of atosiban (P <
0.0001, Figure 4).

Figure 4. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There were significant
differences for control versus treatment (0 mg vs 5, 10 and 20 mg) (P < 0.0001).
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Discussion
The major hormone in reproduction and the maintenance of pregnancy is
progesterone (Murphy, 2000), produced by the CL. Current research is centered around
progesterone production, CL lifespan, and endocrine/exocrine factors that control the CL.
One factor proposed to affect progesterone production is oxytocin. Atosiban is a
combined oxytocin and vasopressin receptor antagonist, which was used in this
experiment to test the proposed mechanisms by which oxytocin might influence
progesterone secretion as measured by its concentration in the posterior vena cava of
ewes. Intravenous injections of atosiban had a significant effect on log10 concentrations
of progesterone, both during and after treatment. There were similar effects during and
after treatment log10 concentrations of progesterone. Mean progesterone concentrations
were reduced in ewes treated with (5, 10 or 20 mg) atosiban compared to the control
ewes. The observed reduction in progesterone fits with the earlier study by Mankey
(2009), who infused atosiban directly into the CL. Thus, the current data confirmed the
hypothesis that atosiban reduced the progesterone in response to treatment.
During the post treatment phase there was a decrease in the progesterone in the
control ewes and an increase in the concentration of progesterone in ewes treated with 10
mg of atosiban compared to during treatment. However, mean progesterone
concentrations for all treated groups remained lower post treatment than in the control
group. Nevertheless, there was a rebound in the concentration of progesterone from
suppression by atosiban in ewes treated with 10 mg.
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Atosiban has been found to be a “biased agonist” when cultured with human
oxytocin receptors (Reversi et al., 2005). Human oxytocin receptors have been shown to
associate to Gq, Gi and Gs proteins (Strakova & Soloff, 1997). Coupling to Gq is
responsible for phospholipase C activation, which is responsible for increased
intracellular calcium (Sanborn, 2001). Atosiban acted as a competitive antagonist on the
oxytocin receptor/Gq coupling and displayed agonistic properties on the OTR/Gi pathway,
but no effects on the OTR/Gs pathway. However, atosiban lead to persistent ERK1/2
activation and p21 induction and inhibited oxytocin-cell growth in kidney cells and
prostate cells infected with oxytocin receptors (Reversi et al., 2005).
Similar to atosiban, oxytocin has demonstrated two different mechanisms of
action. A low concentration of 4 i.u/mL oxytocin stimulated progesterone production
when cultured with 10 i.u/mL of hCG on human luteal cells (Tan et al., 1982). However,
400 or 800 i.u/mL of oxytocin inhibited progesterone production in the same system. In
contrast, Richardson and Masson (1985) incubated bovine luteal cells with 10 i.u/mL of
hCG and 500 i.u/mL of oxytocin and progesterone production was not inhibited.
Lutz and others (1991) used mini-pumps or jugular infusions of oxytocin to the
CL beginning on day 10 and observed lengthened diestrus as a result of prolonged
progesterone secretion. In saline-infused heifers normal PGF2! secretion occurred on day
16 in response to a challenge injection of oxytocin. These results demonstrated that
chronic oxytocin treatment inhibited episodic pulses of PGF2!. Miyamoto and Schams
(1991) utilized a microdialysis system in bovine CL and found that the combination of
bovine LH and oxytocin stimulated progesterone secretion in a dose dependent manner.
The greatest effect was found on day 5 of the estrous cycle and was found to decrease
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from day 8 to 18. Their overall interpretation of the results was that cell-to-cell
interactions were needed for progesterone to be stimulated by oxytocin (Miyamoto and
Schams, 1991).
Atosiban could have vasoconstrictive properties, which was not measured in the
experiment. In the previous study (Mankey, 2009) did not find a difference in luteal
progesterone, but found a difference in circulating concentrations of progesterone.
Oxytocin has been found to be a vasoconstrictor in rats (Altura and Altura, 1977).
Another source of vasoconstriction could be from arginine vasopressin activation, which
is a known vasocontrictor (Du Vigneaud et al., 1953). Bovine CL produced arginine
vasopressin (Wathes et al., 1983). When porcine and bovine luteal cells were cultured
separately with either oxytocin or vasopressin; the vasopressin was more effective at
reducing progesterone concentrations than oxytocin (Pitzel et al., 1988).
In general, the roles of oxytocin are not fully understood in any species. This
uncertainty is further displayed by the previous experiment conducted by Mankey (2009).
When atosiban was delivered directly into the CL via a mini-osmotic pump it appeared to
decrease progesterone. However, there was not a significant difference among doses of
atosiban in progesterone concentrations after an injection of PGF2!. In a second
experiment, the negative effect of atosiban on progesterone was confirmed. Progesterone
concentrations were decreased significantly during the 48-hour sampling period when 5
!g/h of atosiban was continuously delivered via mini-pump.
The results of the current study are similar to those found by Mankey (2009). A
reduction in the concentration of progesterone in ewes treated with atosiban was found in
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both studies. The differences in dose and route of administration did not appear to alter
the outcome of the present study. The previous study used an osmotic-mini-pump to
deliver the atosiban directly into the CL and delivered the doses constantly for 14 days.
However, in the current study, the treatments were delivered via bolus intravenous
injections every hour for four hours beginning with time zero and stopping at time 180
minutes. When comparing the dose amounts from the two experiments, the previous
experiment used a lower amount of atosiban than did the current experiment. The
increased dose was chosen on the basis of human research in which was used to halt
uterine contractions.
The “biased agonist” theory could be used to explain the results from this
experiment. Perhaps one dose of atosiban can be an agonist while another dose can be an
antagonist. During the treatment phase of the experiment, progesterone decreased in the
treated groups. Only in the 10 mg group, progesterone increased in the post treatment
phase compared to the treatment phase. The degree of progesterone suppression was less
in the post treatment period in the ewes treated with 10 mg of atosiban compared to the
ewes treated with 5 or 20 mg. The present results, are similar to those of Mankey (2009)
in terms of the overall the reduction in progesterone concentrations.
Conclusion
The main conclusion from this experiment is that atosiban reduced circulating
concentrations of progesterone. Examination of the mechanism for this effect will require
measurements of blood flow, in view of the observation by Mankey (2009) that
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progesterone in the CL did not change. It also will be appropriate to examine changes in
steroidogenic genes in the large and small luteal cells.
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